Gregory Ho

Spring Mountain Capital LP /Private Equity/ (Spring Mountain Capital) is a private equity subsidiary of Spring Mountain Capital LP founded in 2001 by John Laundon Steffens. The firm is headquartered in New York.

Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT.

Museum of Chinese in America operates to promote Chinese American history. It curates and displays its collections, presents exhibits and multimedia productions, and offers education programs and curriculum used in schools. The company was founded by Jack Tchen and Charlie Lai in 1980 and is headquartered in New York, NY.

Spring Mountain Capital LP operates as a investment management firm. It specializes in asset and portfolio management, financial planning, private equity, research, strategies, bonds, hedge funds, consulting, and advisory solutions. The company was founded by John Laundon Steffen in 2001 and is headquartered in New York, NY .

Atlasxomics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New Haven, CT.

New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY.

Allyx Therapeutics is an American clinical-stage biotechnology company founded in 2019 by a group of experienced biopharma industry executives, venture capitalists, and scientific experts. The company is based in an undisclosed location and aims to deliver a novel approach to preserve and protect synapses for people living with neurodegenerative diseases. Its lead compound, alx-001, is a first-in-class oral therapy with a unique mechanism of action at mglur5 currently in clinical development in Alzheimer's disease. The company is developing an oral drug that demonstrates reversal of learning and memory deficits due to Alzheimer's disease. The company was founded by Timothy Siegert, Stephen M. Bloch, Paul R. Fonteyne, and Stephen M. Bloch has been the CEO since incorporation.

Venture For America, Inc. operates as a fellowship program that places recent graduates at startups in cities with emerging entrepreneurial ecosystems, forging a community of entrepreneurs committed to building companies. The company was founded in 2011 and is headquartered in New York, NY.